Published in Cell Mol Life Sci on May 17, 2011
Antimicrobial compounds in tears. Exp Eye Res (2013) 0.97
Dry eye disease and microbial keratitis: is there a connection? Ocul Surf (2013) 0.92
Protective role of murine β-defensins 3 and 4 and cathelin-related antimicrobial peptide in Fusarium solani keratitis. Infect Immun (2013) 0.86
Calcium regulation by thermo- and osmosensing transient receptor potential vanilloid channels (TRPVs) in human conjunctival epithelial cells. Histochem Cell Biol (2012) 0.81
Antimicrobial peptides and wound healing: biological and therapeutic considerations. Exp Dermatol (2016) 0.80
Therapeutic potential of the antimicrobial peptide OH-CATH30 for antibiotic-resistant Pseudomonas aeruginosa keratitis. Antimicrob Agents Chemother (2014) 0.79
Peptide therapeutics for treating ocular surface infections. J Ocul Pharmacol Ther (2014) 0.78
Role of Pattern Recognition Receptors in the Modulation of Antimicrobial Peptide Expression in the Corneal Epithelial Innate Response to F. solani. Invest Ophthalmol Vis Sci (2017) 0.75
In vitro studies on the antimicrobial peptide human beta-defensin 9 (HBD9): signalling pathways and pathogen-related response (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc (2014) 0.75
Age-related Defects in Ocular and Nasal Mucosal Immune System and the Immunopathology of Dry Eye Disease. Ocul Immunol Inflamm (2014) 0.75
Influence of Amphibian Antimicrobial Peptides and Short Lipopeptides on Bacterial Biofilms Formed on Contact Lenses. Materials (Basel) (2016) 0.75
Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol (2006) 10.15
Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science (1999) 7.86
Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic. J Biol Chem (2000) 6.19
Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease. Invest Ophthalmol Vis Sci (2001) 3.72
Spectrum of microbial keratitis in South Florida. Am J Ophthalmol (1980) 3.61
An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J Clin Invest (2003) 3.19
Direct inactivation of viruses by human granulocyte defensins. J Virol (1986) 3.00
Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein. Infect Immun (1995) 2.87
Spectrum of fungal keratitis at Wills Eye Hospital, Philadelphia, Pennsylvania. Cornea (2000) 2.85
Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjögren's syndrome keratoconjunctivitis sicca. Curr Eye Res (1999) 2.75
Many chemokines including CCL20/MIP-3alpha display antimicrobial activity. J Leukoc Biol (2003) 2.62
Synergistic and additive killing by antimicrobial factors found in human airway surface liquid. Am J Physiol Lung Cell Mol Physiol (2000) 2.55
Identification of a novel, multifunctional beta-defensin (human beta-defensin 3) with specific antimicrobial activity. Its interaction with plasma membranes of Xenopus oocytes and the induction of macrophage chemoattraction. Cell Tissue Res (2001) 2.45
Cutting edge: IFN-inducible ELR- CXC chemokines display defensin-like antimicrobial activity. J Immunol (2001) 2.38
Epidemiology of ocular herpes simplex. Incidence in Rochester, Minn, 1950 through 1982. Arch Ophthalmol (1989) 2.24
Conjunctival T-cell subpopulations in Sjögren's and non-Sjögren's patients with dry eye. Invest Ophthalmol Vis Sci (2002) 2.19
Anti-fungal activity of cathelicidins and their potential role in Candida albicans skin infection. J Invest Dermatol (2005) 2.19
Modulation of the in vitro candidacidal activity of human neutrophil defensins by target cell metabolism and divalent cations. J Clin Invest (1988) 2.18
The human antibacterial cathelicidin, hCAP-18, is synthesized in myelocytes and metamyelocytes and localized to specific granules in neutrophils. Blood (1997) 2.16
The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor. J Immunol (2003) 2.15
Review of epidemiological features, microbiological diagnosis and treatment outcome of microbial keratitis: experience of over a decade. Indian J Ophthalmol (2009) 2.09
Alternative mechanisms of action of cationic antimicrobial peptides on bacteria. Expert Rev Anti Infect Ther (2007) 2.06
Risk factors and causative organisms in microbial keratitis. Cornea (2008) 2.01
Human defensin gene copy number polymorphisms: comprehensive analysis of independent variation in alpha- and beta-defensin regions at 8p22-p23. Genomics (2005) 1.97
The roles of cathelicidin LL-37 in immune defences and novel clinical applications. Curr Opin Hematol (2009) 1.92
Tear fluid gelatinase B activity correlates with IL-1alpha concentration and fluorescein clearance in ocular rosacea. Invest Ophthalmol Vis Sci (1999) 1.74
The human beta-defensins (-1, -2, -3, -4) and cathelicidin LL-37 induce IL-18 secretion through p38 and ERK MAPK activation in primary human keratinocytes. J Immunol (2005) 1.73
Innate defence of the eye by antimicrobial defensin peptides. Lancet (1998) 1.72
Evaluation of the effects of peptide antibiotics human beta-defensins-1/-2 and LL-37 on histamine release and prostaglandin D(2) production from mast cells. Eur J Immunol (2001) 1.68
Synergistic actions of antibacterial neutrophil defensins and cathelicidins. Inflamm Res (2000) 1.67
Osmolarity of tear microvolumes in keratoconjunctivitis sicca. Arch Ophthalmol (1978) 1.65
Antimicrobial characterization of human beta-defensin 3 derivatives. Antimicrob Agents Chemother (2003) 1.63
Dry eye disease: the scale of the problem. Surv Ophthalmol (2001) 1.62
Toll-like receptor 2-mediated expression of beta-defensin-2 in human corneal epithelial cells. Microbes Infect (2005) 1.62
Human cathelicidin (LL-37), a multifunctional peptide, is expressed by ocular surface epithelia and has potent antibacterial and antiviral activity. Curr Eye Res (2005) 1.58
Purification and characterization of human neutrophil peptide 4, a novel member of the defensin family. J Biol Chem (1989) 1.56
Innate immune response of corneal epithelial cells to Staphylococcus aureus infection: role of peptidoglycan in stimulating proinflammatory cytokine secretion. Invest Ophthalmol Vis Sci (2004) 1.53
Synergistic effect of antibacterial agents human beta-defensins, cathelicidin LL-37 and lysozyme against Staphylococcus aureus and Escherichia coli. J Dermatol Sci (2005) 1.53
Human beta-defensins: differential activity against candidal species and regulation by Candida albicans. J Dent Res (2005) 1.50
Ocular surface epithelia express mRNA for human beta defensin-2. Exp Eye Res (1999) 1.50
Keratinocytes store the antimicrobial peptide cathelicidin in lamellar bodies. J Invest Dermatol (2005) 1.48
Tear osmolarity--a new gold standard? Adv Exp Med Biol (1994) 1.47
Antimicrobial defensin peptides of the human ocular surface. Br J Ophthalmol (1999) 1.44
Antimicrobial peptides: natural effectors of the innate immune system. Semin Immunopathol (2007) 1.43
Defensin expression by the cornea: multiple signalling pathways mediate IL-1beta stimulation of hBD-2 expression by human corneal epithelial cells. Invest Ophthalmol Vis Sci (2003) 1.39
Effect of defensins on interleukin-8 synthesis in airway epithelial cells. Am J Physiol (1997) 1.34
Cathelicidin-deficient (Cnlp -/- ) mice show increased susceptibility to Pseudomonas aeruginosa keratitis. Invest Ophthalmol Vis Sci (2007) 1.33
In human epidermis, beta-defensin 2 is packaged in lamellar bodies. Exp Mol Pathol (2003) 1.33
The role of antimicrobial peptides at the ocular surface. Ophthalmic Res (2008) 1.32
Complementary DNA sequence of rabbit CAP18--a unique lipopolysaccharide binding protein. Biochem Biophys Res Commun (1991) 1.30
Human alpha-defensin 1 (HNP-1) inhibits adenoviral infection in vitro. Regul Pept (2001) 1.30
Microbial keratitis pathogens and antibiotic susceptibilities: a 5-year review of cases at an urban county hospital in north Texas. Eye Contact Lens (2007) 1.29
Host defense peptides and their antimicrobial-immunomodulatory duality. Immunobiology (2010) 1.28
Flagellin suppresses the inflammatory response and enhances bacterial clearance in a murine model of Pseudomonas aeruginosa keratitis. Infect Immun (2007) 1.27
Fungal keratitis at the new york eye and ear infirmary. Cornea (2006) 1.22
Neutrophil defensins induce histamine secretion from mast cells: mechanisms of action. J Immunol (1999) 1.19
Modulation of corneal epithelial innate immune response to pseudomonas infection by flagellin pretreatment. Invest Ophthalmol Vis Sci (2007) 1.17
Regulation of neovascularization by human neutrophil peptides (alpha-defensins): a link between inflammation and angiogenesis. FASEB J (2004) 1.17
Beta-defensin-2 promotes resistance against infection with P. aeruginosa. J Immunol (2009) 1.14
Multifunctional roles of human cathelicidin (LL-37) at the ocular surface. Invest Ophthalmol Vis Sci (2006) 1.13
Inhibition of pathologic retinal neovascularization by alpha-defensins. Blood (2005) 1.13
Maintaining corneal integrity how the "window" stays clear. Prog Histochem Cytochem (2001) 1.11
Candidacidal effects of two antimicrobial peptides: histatin 5 causes small membrane defects, but LL-37 causes massive disruption of the cell membrane. Biochem J (2005) 1.11
Copy number variation of beta-defensins and relevance to disease. Cytogenet Genome Res (2009) 1.09
Expression of human beta-defensins in conjunctival epithelium: relevance to dry eye disease. Invest Ophthalmol Vis Sci (2003) 1.09
Beta-defensins 2 and 3 together promote resistance to Pseudomonas aeruginosa keratitis. J Immunol (2009) 1.08
Antifungal susceptibility for common pathogens of fungal keratitis in Shandong Province, China. Am J Ophthalmol (2008) 1.07
Mouse beta-defensin-14, an antimicrobial ortholog of human beta-defensin-3. Antimicrob Agents Chemother (2008) 1.07
Ocular surface expression and in vitro activity of antimicrobial peptides. Curr Eye Res (2007) 1.06
Predisposing factors and etiologic diagnosis of ulcerative keratitis. Cornea (2008) 1.04
Using osmolarity to diagnose dry eye: a compartmental hypothesis and review of our assumptions. Adv Exp Med Biol (2002) 1.03
Large-scale synthesis and functional elements for the antimicrobial activity of defensins. Biochem J (2000) 1.03
Proteomic analysis of human tears: defensin expression after ocular surface surgery. J Proteome Res (2004) 1.02
High expression of chemokines Gro-alpha (CXCL-1), IL-8 (CXCL-8), and MCP-1 (CCL-2) in inflamed human corneas in vivo. Arch Ophthalmol (2003) 1.02
Up-regulated gene expression in the conjunctival epithelium of patients with Sjögren's syndrome. Exp Eye Res (2003) 1.02
Interleukin-1 receptor-1-deficient mice show attenuated production of ocular surface inflammatory cytokines in experimental dry eye. Cornea (2008) 1.02
Human beta-defensin 2 is up-regulated during re-epithelialization of the cornea. Curr Eye Res (2001) 1.01
Expression of human beta-defensins in intraocular tissues. Invest Ophthalmol Vis Sci (2000) 1.01
Evaluation of a theta-defensin in a Murine model of herpes simplex virus type 1 keratitis. Invest Ophthalmol Vis Sci (2007) 1.00
Inducible expression of beta defensins by human respiratory epithelial cells exposed to Aspergillus fumigatus organisms. BMC Microbiol (2009) 1.00
Neutrophil defensins stimulate the release of cytokines by airway epithelial cells: modulation by dexamethasone. Inflamm Res (2002) 1.00
The spectrum of antimicrobial peptide expression at the ocular surface. Invest Ophthalmol Vis Sci (2005) 0.99
Antifungal activities of human beta-defensins HBD-1 to HBD-3 and their C-terminal analogs Phd1 to Phd3. Antimicrob Agents Chemother (2008) 0.99
Role of defensins in corneal epithelial barrier function against Pseudomonas aeruginosa traversal. Infect Immun (2010) 0.98
Exposure of human corneal epithelial cells to contact lenses in vitro suppresses the upregulation of human beta-defensin-2 in response to antigens of Pseudomonas aeruginosa. Exp Eye Res (2007) 0.98
Fusarium keratitis in Mexico. Cornea (2009) 0.97
Detection of natural peptide antibiotics in human nasolacrimal ducts. Invest Ophthalmol Vis Sci (2001) 0.97
LL-37 via EGFR transactivation to promote high glucose-attenuated epithelial wound healing in organ-cultured corneas. Invest Ophthalmol Vis Sci (2009) 0.97
Corneal melt as the initial presentation of primary Sjögren's syndrome. J Rheumatol (2001) 0.97
Staphylococcus aureus lipoproteins trigger human corneal epithelial innate response through toll-like receptor-2. Microb Pathog (2007) 0.97
A novel cationic-peptide coating for the prevention of microbial colonization on contact lenses. J Appl Microbiol (2008) 0.94
Prevention of bacterial colonization of contact lenses with covalently attached selenium and effects on the rabbit cornea. Cornea (2006) 0.94
Defensins HNP1 and HBD2 stimulation of wound-associated responses in human conjunctival fibroblasts. Invest Ophthalmol Vis Sci (2006) 0.94
Effects of magainins on ameba and cyst stages of Acanthamoeba polyphaga. Antimicrob Agents Chemother (1992) 0.92
Human beta-defensin 2 is induced by interleukin-1beta in the corneal epithelial cells. Exp Mol Med (2004) 0.92
The corneal expression of antimicrobial peptides during experimental fungal keratitis. Curr Eye Res (2010) 0.91
Roles of human beta-defensins in innate immune defense at the ocular surface: arming and alarming corneal and conjunctival epithelial cells. Histochem Cell Biol (2010) 0.90
Recent outbreaks of atypical contact lens-related keratitis: what have we learned? Am J Ophthalmol (2010) 0.90
The use of antimicrobial peptides in ophthalmology: an experimental study in corneal preservation and the management of bacterial keratitis. Trans Am Ophthalmol Soc (2002) 0.90
A review of antimicrobial peptides and their therapeutic potential as anti-infective drugs. Curr Eye Res (2005) 1.97
Human cathelicidin (LL-37), a multifunctional peptide, is expressed by ocular surface epithelia and has potent antibacterial and antiviral activity. Curr Eye Res (2005) 1.58
Cathelicidin-deficient (Cnlp -/- ) mice show increased susceptibility to Pseudomonas aeruginosa keratitis. Invest Ophthalmol Vis Sci (2007) 1.33
Aldehyde dehydrogenase (ALDH) 3A1 expression by the human keratocyte and its repair phenotypes. Exp Eye Res (2006) 1.25
Dimensions and morphology of the cornea in three strains of mice. Invest Ophthalmol Vis Sci (2009) 1.16
Conjunctival cytokine expression in symptomatic moderate dry eye subjects. Invest Ophthalmol Vis Sci (2006) 1.15
Multifunctional roles of human cathelicidin (LL-37) at the ocular surface. Invest Ophthalmol Vis Sci (2006) 1.13
Expression of human beta-defensins in conjunctival epithelium: relevance to dry eye disease. Invest Ophthalmol Vis Sci (2003) 1.09
Ocular surface expression and in vitro activity of antimicrobial peptides. Curr Eye Res (2007) 1.06
Antibacterial activities of poly(amidoamine) dendrimers terminated with amino and poly(ethylene glycol) groups. Biomacromolecules (2007) 1.05
Toll-like receptors in ocular surface disease. Exp Eye Res (2010) 1.05
Thy-1 distinguishes human corneal fibroblasts and myofibroblasts from keratocytes. Exp Eye Res (2004) 1.04
Interleukin-1 receptor-1-deficient mice show attenuated production of ocular surface inflammatory cytokines in experimental dry eye. Cornea (2008) 1.02
Toll-like receptor activation modulates antimicrobial peptide expression by ocular surface cells. Exp Eye Res (2010) 1.00
The effect of interleukin-1 on cytokine gene expression by human corneal epithelial cells. Exp Eye Res (2005) 0.98
Antibacterial activity and cytotoxicity of PEGylated poly(amidoamine) dendrimers. Mol Biosyst (2009) 0.92
Pathways of corneal and ocular surface inflammation: a perspective from the cullen symposium. Ocul Surf (2005) 0.92
Dry eye disease and microbial keratitis: is there a connection? Ocul Surf (2013) 0.92
In vitro activity of human beta-defensin 2 against Pseudomonas aeruginosa in the presence of tear fluid. Antimicrob Agents Chemother (2007) 0.88
Toll-like receptor expression and activation in mice with experimental dry eye. Invest Ophthalmol Vis Sci (2013) 0.87
Protective role of murine β-defensins 3 and 4 and cathelin-related antimicrobial peptide in Fusarium solani keratitis. Infect Immun (2013) 0.86
Effect of hyperosmolality on beta-defensin gene expression by human corneal epithelial cells. Cornea (2006) 0.85
Effect of preservative-free artificial tears on the antimicrobial activity of human beta-defensin-2 and cathelicidin LL-37 in vitro. Eye Contact Lens (2005) 0.83
The TFOS International Workshop on Contact Lens Discomfort: report of the contact lens interactions with the ocular surface and adnexa subcommittee. Invest Ophthalmol Vis Sci (2013) 0.83
The diagnosis and characteristics of moderate dry eye in non-contact lens wearers. Eye Contact Lens (2005) 0.81
Elevated nerve growth factor in dry eye associated with established contact lens wear. Eye Contact Lens (2009) 0.80
Esculentin-1a(1-21)NH2: a frog skin-derived peptide for microbial keratitis. Cell Mol Life Sci (2014) 0.78
"Click" immobilization on alkylated silicon substrates: model for the study of surface bound antimicrobial peptides. Chemistry (2011) 0.78
Localization of antimicrobial peptides on polymerized liposomes leading to their enhanced efficacy against Pseudomonas aeruginosa. Mol Biosyst (2011) 0.77